About FlightPath Biosciences
FlightPath Biosciences is a private company based in Birmingham, Michigan, incorporated in 2019 in Delaware. It has reported $9,586,826 raised in two offerings on Form D since April 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2023 | Feb 15, 2023amended Oct 24, 2024 | $8,064,826of $9.0M target | 17 | $474K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Feb 12, 2020 | Apr 17, 2020amended Dec 16, 2021 | $1,522,000of $5.0M target | 1 | $1.5M | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $9,586,826 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on FlightPath Biosciences's Form D filed Oct 24, 2024.
Earlier filings also listed Mark de Souza (executive officer and director, last listed Dec 2021).